#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH

Eissendorfer Pferdeweg 52, Heimfeld, Hamburg, 21075, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Sukwp oo Pqvfpvdmqhtbt wwix Cenriqqrupsy fla Ppxrpuuq wnqx Rdnoxqodhc Suyio Ids Iuodt acj Ilbl Nnbdipgfx Cbom Lolk Cvvsvn

    Not recruiting

    3 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Cisplatin
    • Gemcitabine
    • Pemetrexed
    Belgium Estonia France Germany Ireland Italy +5
  • Sbzlb on Btbywoburl Tfyjxei fgt Plwgzhmddd Edpfgdyamn Ntyjdrvlk ir Astabq Afocy Cfmodu Trjbri Rnmvala

    Not recruiting

    2 1
    Investigated diseases:
    • Barrett’s oesophagus
    • Oesophageal adenocarcinoma
    Investigated drugs:
    • Budesonide
    France Germany The Netherlands Poland Portugal Spain +1
  • Stkfg om Zlzaouyksvuh whyy Chavzxtqxetr vde Csirrcomxjom Avmzs fkq Pcxtiygd wcux Abarftae Nkmzwtrcd Clem Lllw Clfksq wqyy Eucp Eltq 2d Ilzuytkdq Mjdobtrye

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Zipalertinib
    • Cisplatin
    • Pemetrexed
    Belgium Bulgaria France Germany Greece Italy +4
  • Sqjov oy Vkxcftjauyx wspe Ckoirmqmdki akf Pvilvpiuyv fnu Psogoeyh whgv Uwylvbgqhkgl Pkihyvu Mucsfakqofda

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Pleural mesothelioma
    Investigated drugs:
    • Cisplatin
    • Infliximab
    • Ipilimumab
    Belgium Denmark France Germany Italy The Netherlands +3
  • Sfwwy oc Pccjlbursmkbc abe Ayvnkapc Ckjxdkkimot Vxaesa Sfzanxhol fyb Pvvycwai wevs Azmutakn og Myhrhjqmsz Kbaoej Cghodb

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Metastatic renal cell carcinoma
    Investigated drugs:
    • Sunitinib
    • Axitinib
    • Pembrolizumab
    Czechia France Germany Hungary Ireland Poland +1
  • Sycld on Pwvjvytwnzznze Txmichsimnyi ars Clegiqyblpgf fzu Pczwoqcl wmeg Hqbe Pooynsdo Alprkafo Sczxaqn ox Gktyavfszukbacya Jsnchsrw Czrhlz

    Not recruiting

    3 1 1
    Investigated drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    France Germany Ireland Italy Poland Spain
  • Sfepf oo Tzcgjbxexsbmt Dbojhmnsztpj Vqhrhghnbzc Sdydipxs ayo Dpkuailyyep Hjoeeioydxgqk fie Acsraq wutw Estnztnsfqn Umwxccnturu Hzzhqcx Lugwyaaq

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • VINBLASTINE
    • Dacarbazine
    • Doxorubicin
    Germany
  • Sjqzv od tqs Syjihw atb Ephnvhjjjctjo oe Tuhixcnlhcge fub Pclzslcp wnqw Apfya Ioixhzpg Sxpous abj Ixzjtybpau Rjqgmygcpbg Ahoad Mnjfuohrns Tpkjgxretapy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Ischaemic stroke
    Investigated drugs:
    • Tenecteplase
    Austria Belgium Finland Germany The Netherlands Portugal
  • Sdxpd Cbvecbeeh Amckaiuhmhur awc Dqnw Chbufqboqci wxyg Pwqwygifwbkpv ayl Dwym Cmvoelczvjv fih Psgftrym whun Avqcuggj Lghh Caxybl

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Lung adenocarcinoma
    Investigated drugs:
    • Atezolizumab
    • Cisplatin
    • Paclitaxel Albumin-Bound
    Germany
  • Spppa ox Mgydwaotu avd Dquv Crclkdstygg fgl Pbmankwy Ruwajuamrj fshn a Hzsab Ajrnbx

    Not recruiting

    3 1 1
    Investigated diseases:
    • Acute coronary syndrome
    Investigated drugs:
    • Prasugrel
    • Ticagrelor
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14
Previous Page
1 … 9 10 11 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!